Cargando…

Characterization of HIV-1 subtypes in a Portuguese cohort

INTRODUCTION: Distribution of HIV-1 subtypes is variable around the world, with the most common subtype in western Europe being subtype B. The aim our study was to describe the prevalence of different HIV-1 subtypes in newly diagnosed patients and identify demographic and epidemiological characteris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocha Pereira, Nuno, Duro, Raquel, Piñero, Carmela, Malheiro, Luís, Soares, Jorge, Serrão, Rosário, Sarmento, António
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P151
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225332/ https://www.ncbi.nlm.nih.gov/pubmed/25397433 http://dx.doi.org/10.7448/IAS.17.4.19683

Ejemplares similares

Primary drug resistance at diagnosis of HIV-1 infection: a Portuguese cohort
por: Rocha Pereira, Nuno, et al.
Publicado: (2014)

Hospital discharge processes: Policy changes in England in response to COVID-19
por: Harrison, L.
Publicado: (2022)

Prevention of mother-to-child transmission: experience of a Portuguese centre
por: Piñeiro, Carmela, et al.
Publicado: (2014)

Lung cancer in HIV-infected patients
por: Palacios, R, et al.
Publicado: (2012)

Influence of temperature and light on total phenolic compounds during natural orange juice storage
por: Capitão, C., et al.
Publicado: (2021)

Acceptability of PrEP among HIV negative Portuguese men who have sex with men that attended 2014 Lisbon pride fair
por: Miguel Rocha, Luís, et al.
Publicado: (2014)

Clinical and laboratorial impact of antiretroviral therapy in a cohort of Portuguese patients chronically infected with HIV-2
por: Miranda, Ana, et al.
Publicado: (2014)

Evolution trends over three decades of HIV infection late diagnosis: the experience of a Portuguese cohort of 705 HIV-infected patients
por: Claudia Miranda, Ana, et al.
Publicado: (2014)

High frequency of antiviral drug resistance and non-b subtypes in HIV-1 patients failing antiviral therapy in Cuba
por: Kouri, Vivian, et al.
Publicado: (2014)

Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany
por: Andrea, Hauser, et al.
Publicado: (2014)

La pandémie COVID-19 est associée à des mélanomes diagnostiqués à un stade plus avancé
por: Skowron, F., et al.
Publicado: (2022)

Association of nitrogen-balance trajectories with clinical outcomes in critically ill COVID-19 patients : A retrospective cohort study
por: Dupuis, C., et al.
Publicado: (2023)

Gag drug resistance mutations in HIV-1 subtype C patients, failing a protease inhibitor inclusive treatment regimen, with detectable lopinavir levels
por: Kelly Pillay, Sameshnee, et al.
Publicado: (2014)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
por: Libertone, Raffaella, et al.
Publicado: (2014)

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics
por: Ammassari, Adriana, et al.
Publicado: (2014)

Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXA
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Should screening for Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-men who have sex with men be recommended?
por: Pérez-Hernández, Isabel, et al.
Publicado: (2014)

Clinical and immunological presentation of new HIV-infected patients in an outpatient clinic
por: Quintas, Edna, et al.
Publicado: (2010)

HIV infection early diagnosis experience in primary care
por: Jover Diaz, Francisco, et al.
Publicado: (2014)

Monitoring of the lactonase activity of paraoxonase-1 enzyme in HIV-1-infection
por: Dias, Clara, et al.
Publicado: (2014)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Acceptability and confidence in antiretroviral generics of physicians and HIV-infected patients in France
por: Allavena, Clotilde, et al.
Publicado: (2014)

Analysis of hepatitis non-treatment causes in a cohort of HCV and HCV/HIV infected patients
por: Pereira, Karen, et al.
Publicado: (2014)

Determinants of HIV outpatient service utilization according to HIV parameters
por: Di Carlo, Paola, et al.
Publicado: (2014)

Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
por: Boura, Márcia, et al.
Publicado: (2014)

Transmission route and reasons for HIV testing among recently diagnosed HIV patients in HIV-TR cohort, 2011–2012
por: Dokuzoguz, Basak, et al.
Publicado: (2014)

Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera(®)). Efficacy and safety analysis. GeSida Study 8114
por: Pérez-Hernández, Isabel A, et al.
Publicado: (2014)

Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients
por: Caldas, C, et al.
Publicado: (2010)

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
por: Ortega Gonzalez, Enrique, et al.
Publicado: (2014)

Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients
por: Luis Casado, Jose, et al.
Publicado: (2014)

Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2014)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Efficacy, safety, and lack of interactions with the use of raltegravir in HIV-infected patients undergoing antineoplastic chemotherapy
por: Bañón, Sara, et al.
Publicado: (2014)

HCV triple therapy in co-infection HIV/HCV is not associated with a different risk of developing major depressive disorder
por: Fialho, Renata, et al.
Publicado: (2014)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
por: Minguez, Carlos, et al.
Publicado: (2014)

Recreational drugs and HIV in Europe: current use of recreational drugs and principal HIV guidelines related recommendations
por: Garin Escriva, Noe, et al.
Publicado: (2014)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9ntd02rb9jraosc2mnnaraf5m3